1[1]De Lena M,Zucali R,Viganotti G,et al.Combined chemotherapy-radiotherapy approach in locally advanced (T3bT4) breast cancer[J].Cancer Chemotherap Pharmocol,1978,1 (1):53-59.
2[2]Smith IE,Heys SD,Hutheon AW,et al.Neoadjuvant chemotherapy in breast cancer:significantly enhanced response with docetaxel[J].J Clin Oncol,2002,20 (6):1456-1466.
3[3]Veronesi U,Cascinelli N,Mariani L,et al.Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer[J].N Engl J Med,2002,347(16):1227-1232.
4[4]Fisher B,Anderson S,Bryant J,et al.Twenty-year followup of a randomized trial comparing total mastectomy,lumpectomy,and lumpectomy plus irradiation for the treatment of invasive breast cancer[J].N Engl J Med,2002,347(16):1233-1241.
5[5]Bonadonna G,Valagussa P.Primary chemotherapy in operable breast cancer[J].Semin Oncol,1996,23 (4):664-674.
6[6]Amat S,Bongnon XP,Penault-Llorca F,et al.Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate[J].Br J Cancer,2003,88(9):1339-1345.
7[7]Bonadonna G,Veronesi U,Brambilla C,et al.Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more[J].J Natl Cancer Inst,1990,82(19):1539-1545.
8[8]Bonadonna G,Valgussa P,Brambilli C,et al.Primary chemotherapy in operable breast cancer:eight-year experience at the Milan Cancer Institute[J].J Clin Oncol,1998,16(1):93-100.
9[9]van der Hage J,van der Velde CJH,Julien JP,et al.Preoperative chemotherapy in primary operable breast cancer:results from the European Organization for Research and Treatment of Cancer trial 10902[J].J Clin Oncol,2001,19 (22):4224-4237.
10[10]Newman LA,Buzdar AU,Singletary SE,et al.A prospective trial of preoperative chemotherapy in resectable breast cancer:predictors of breast-conservation therapy feasibility[J].Ann Surg Oncol,2002,9 (3):228-234.
